Patents by Inventor Dirk Kessler
Dirk Kessler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8695090Abstract: A method and apparatus for classifying behavior of an application based on its data access pattern is described. In one embodiment, the method includes monitoring file access events associated with an application, and determining whether at least one of the file access events indicates the application's attempt to manipulate data of a file. If at least one file access event indicates the application's attempt to manipulate the data within the file, then at least one action is caused to be performed.Type: GrantFiled: October 31, 2008Date of Patent: April 8, 2014Assignee: Symantec CorporationInventors: Ian Barile, Bruce Wootton, Dirk Kessler, Rajesh Upadhyay
-
Publication number: 20140073621Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.Type: ApplicationFiled: November 22, 2013Publication date: March 13, 2014Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Siegfried SCHNEIDER, Dirk KESSLER, Lars van der VEEN, Tobias WUNBERG
-
Patent number: 8671080Abstract: A method and apparatus for managing data loss due to policy violations in temporary files is described. In one embodiment, the method includes monitoring, by a client agent, information content on a client for violations of a policy. The method further includes determining, by the client agent, that a violation of the policy has occurred for content of a temporary file of an application. In one embodiment, the policy violation of the temporary file is correlated, by the client agent, with an original file of the application.Type: GrantFiled: June 24, 2011Date of Patent: March 11, 2014Assignee: Symantec CorporationInventors: Rajesh Upadhyay, Dirk Kessler
-
Publication number: 20140045719Abstract: The trivalent phosphorous atom of a compound is reacted with a reagent in such a manner that a stable phosphate mimetic or a specifier is formed. Phosphoramidites with a phosphorous atom containing at least one hydroxyl residue which is provided with a protective group are reacted for this purpose with a free hydroxyl group: In the first synthesis cycle the hydroxyl group is linked to a solid support via a cleavable or non-cleavable linker. In further synthesis cycles the hydroxyl group is created by cleavage of the protective group from the growing oligomer. This results in formation of a phosphorous acid triester which is reacted with azides. By selecting suitable monomers for the synthesis which have a defined stereoconformation compounds of Formula 1 are produced in a stereocontrolled manner.Type: ApplicationFiled: September 13, 2013Publication date: February 13, 2014Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Dieter Heindl, Dirk Kessler, Angelika Roesler, Christoph Seidel, Wilma Thuer
-
Patent number: 8633183Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.Type: GrantFiled: January 24, 2011Date of Patent: January 21, 2014Assignee: Boehringer Ingelheim International GmbHInventors: Siegfried Schneider, Dirk Kessler, Lars van der Veen, Tobias Wunberg
-
Patent number: 8618111Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R4R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.Type: GrantFiled: January 24, 2011Date of Patent: December 31, 2013Assignee: Boehringer Ingelheim International GmbHInventors: Siegfried Schneider, Dirk Kessler, Lars van der Veen, Tobias Wunberg
-
Patent number: 8569515Abstract: The trivalent phosphorous atom of a compound is reacted with a reagent in such a manner that a stable phosphate mimetic or a specifier is formed. Phosphoramidites with a phosphorous atom containing at least one hydroxyl residue which is provided with a protective group are reacted for this purpose with a free hydroxyl group: In the first synthesis cycle the hydroxyl group is linked to a solid support via a cleavable or non-cleavable linker. In further synthesis cycles the hydroxyl group is created by cleavage of the protective group from the growing oligomer. This results in formation of a phosphorous acid triester which is reacted with azides. By selecting suitable monomers for the synthesis which have a defined stereoconformation compounds of Formula 1 are produced in a stereocontrolled manner.Type: GrantFiled: May 3, 2011Date of Patent: October 29, 2013Assignee: Roche Diagnostics Operations, Inc.Inventors: Dieter Heindl, Dirk Kessler, Angelika Roesler, Christoph Seidel, Wilma Thuer
-
Patent number: 8566305Abstract: A method and apparatus for defining the scope of a search is described. In one embodiment, user input is received, and the scope is defined, based on the user input, for a search of free-form text for information from any random rows within a tabular structure of source data. In one embodiment, the search is intended for finding, in the free-form text, a sub-set of data fragments that matches information from any single row within the tabular structure of the source data.Type: GrantFiled: December 7, 2009Date of Patent: October 22, 2013Assignee: Symantec CorporationInventors: Kevin T. Rowney, Michael R. Wolfe, Chris Jones, Dirk Kessler, Hai Chen, Eric Bothwell
-
Patent number: 8304556Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.Type: GrantFiled: January 11, 2012Date of Patent: November 6, 2012Assignee: Boehringer Ingelheim International GmbHInventors: Darryl McConnell, Maria Impagnatiello, Dirk Kessler, Oliver Kraemer, Siegfried Schneider, Lars Van Der Veen, Ulrike Weyer-Czernilofsky, Tobias Wunberg
-
Patent number: 8207349Abstract: The present invention encompasses compounds of the general formula (1) in which R1 to R3 are defined as in claim 1, which are suitable for treating diseases which are characterized by excessive or anomalous cell proliferation, and their use for producing a pharmaceutical having the abovementioned properties.Type: GrantFiled: January 11, 2010Date of Patent: June 26, 2012Assignee: Boehringer Ingelheim International GmbHInventors: Bodo Betzemeier, Trixi Brandl, Steffen Breitfelder, Ralph Brueckner, Thomas Gerstberger, Michael Gmachl, Matthias Grauert, Frank Hilberg, Christoph Hoenke, Matthias Hoffmann, Maria Impagnatiello, Dirk Kessler, Christian Klein, Bernd Krist, Udo Maier, Darryl McConnell, Charlotte Reither, Stefan Scheuerer, Andreas Schoop, Norbert Schweifer, Oliver Simon, Martin Steegmaier, Steffen Steurer, Irene Waizenegger, Ulrike Weyer-Czernilofsky, Andreas Zoephel
-
Publication number: 20120108567Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.Type: ApplicationFiled: January 11, 2012Publication date: May 3, 2012Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Darryl McCONNELL, Maria IMPAGNATIELLO, Dirk KESSLER, Oliver KRAEMER, Siegfried SCHNEIDER, Lars VAN DER VEEN, Ulrike WEYER-CZERNILOFSKY, Tobias WUNBERG
-
Publication number: 20120028958Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R4 R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.Type: ApplicationFiled: January 24, 2011Publication date: February 2, 2012Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Siegfried SCHNEIDER, Dirk KESSLER, Lars van der VEEN, Tobias WUNBERG
-
Publication number: 20120028952Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.Type: ApplicationFiled: January 24, 2011Publication date: February 2, 2012Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Siegfried SCHNEIDER, Dirk KESSLER, Lars van der VEEN, Tobias WUNBERG
-
Publication number: 20110281838Abstract: The present invention encompasses compounds of general Formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.Type: ApplicationFiled: July 28, 2009Publication date: November 17, 2011Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Tobias Wunberg, Ralph Brueckner, Dirk Kessler, Oliver Kraemer, Darryl McConnell, Siegfried Schneider, Lars van der Veen
-
Patent number: 8060596Abstract: A computer-implemented method for normalizing data-loss-prevention categorization information, at least a portion of the method being performed by a computing system comprising at least one processor, may identify a data object at a first time. The method may apply a first version of a set of data-loss-prevention rules to the data object to determine a set of categorizations of the data object. The method may distinguish a set of content-based categorizations in the set of categorizations from a set of context-based categorizations in the set of categorizations. The method may apply, based on the set of categorizations, a first data-loss-prevention policy to the data object. The method may identify the data object at a second time, and apply, based on the set of content-based categorizations, a second data-loss-prevention policy to the data object. Various other methods, systems, and computer-readable media are also disclosed.Type: GrantFiled: March 31, 2009Date of Patent: November 15, 2011Assignee: Symantec CorporationInventors: Bruce Wootton, Richard Dandliker, Aleksey Tsibulya, Oskar Bruening, Dirk Kessler
-
Publication number: 20110212861Abstract: The trivalent phosphorous atom of a compound is reacted with a reagent in such a manner that a stable phosphate mimetic or a specifier is formed. Phosphoramidites with a phosphorous atom containing at least one hydroxyl residue which is provided with a protective group are reacted for this purpose with a free hydroxyl group: In the first synthesis cycle the hydroxyl group is linked to a solid support via a cleavable or non-cleavable linker. In further synthesis cycles the hydroxyl group is created by cleavage of the protective group from the growing oligomer. This results in formation of a phosphorous acid triester which is reacted with azides. By selecting suitable monomers for the synthesis which have a defined stereoconformation compounds of Formula 1 are produced in a stereocontrolled manner.Type: ApplicationFiled: May 3, 2011Publication date: September 1, 2011Inventors: Dieter Heindl, Dirk Kessler, Angelika Roesler, Christoph Seidel, Wilma Thuer
-
Patent number: 7996385Abstract: A method and apparatus for defining the scope of a search is described. In one embodiment, user input is received, and the scope is defined, based on the user input, for a search of free-form text for information from any random rows within a tabular structure of source data. In one embodiment, the search is intended for finding, in the free-form text, a sub-set of data fragments that matches information from any single row within the tabular structure of the source data.Type: GrantFiled: November 6, 2008Date of Patent: August 9, 2011Assignee: Symantec CorporationInventors: Kevin T. Rowney, Michael R. Wolfe, Chris Jones, Dirk Kessler, Hai Chen, Eric Bothwell
-
Patent number: 7991747Abstract: A method and apparatus for managing data loss due to policy violations in temporary files is described. In one embodiment, the method includes monitoring, by a client agent, information content on a client for violations of a policy. The method further includes determining, by the client agent, that a violation of the policy has occurred for content of a temporary file of an application. In one embodiment, the policy violation of the temporary file is correlated, by the client agent, with an original file of the application.Type: GrantFiled: March 13, 2009Date of Patent: August 2, 2011Assignee: Symantec CorporationInventors: Rajesh Upadhyay, Dirk Kessler
-
Publication number: 20110118208Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.Type: ApplicationFiled: March 13, 2009Publication date: May 19, 2011Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Darryl Mcconnell, Maria Impagnatiello, Dirk Kessler, Oliver Kraemer, Siegfried Schneider, Lars Van Der Veen, Ulrike Weyer-Czernilofsky, Tobias Wunberg
-
Patent number: 7759470Abstract: The current invention restates substituted indole nucleosides as both terminal as well as internal building blocks of labeled oligonucleotide probes for the detection, analysis and quantitation of nucleic acids. The substituent comprises a linker and a detectable group or a linker and a reactive group for post synthesis coupling. These modified nucleosides grant access to a wide application area. These new substituted indole nucleosides can be used as labeling reagents for the facile preparation of e.g. optimized hybridization probes, Taqman-probes, or molecular beacon probes.Type: GrantFiled: February 16, 2007Date of Patent: July 20, 2010Assignee: Roche Diagnostics Operations, Inc.Inventors: Dieter Heindl, Frank Bergmann, Hans-Peter Josel, Dirk Kessler, Gunter Lampert, Christian Weilke